论文部分内容阅读
本文测定了140例Graves病患者血清TGA,TMA水平。结果表明,治疗前的初患病组(56例),显著高于正常对照组(P<0.001);应用抗甲状腺药物治疗后的临床控制组(43例),显著低于初患病组(P<0.001);控制后复发组(41例),TGA与初患病组无显著差异(P>0.05),而TMA显著高于初患病组(P<0.05)。提示TGA,
This article measured 140 cases of Graves disease serum TGA, TMA levels. The results showed that the initial illness before treatment group (56 cases) was significantly higher than the normal control group (P <0.001); clinical control group (43 cases) treated with anti-thyroid drugs was significantly lower than the initial diseased group P <0.001). There was no significant difference between control group and control group (P> 0.05). TMA was significantly higher than that of the initial disease group (P <0.05). Tip TGA,